rs115205076

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_018100.4(EFHC1):​c.887G>A​(p.Arg296His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000534 in 1,614,096 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R296C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0029 ( 4 hom., cov: 32)
Exomes 𝑓: 0.00028 ( 1 hom. )

Consequence

EFHC1
NM_018100.4 missense

Scores

5
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 1.73

Publications

2 publications found
Variant links:
Genes affected
EFHC1 (HGNC:16406): (EF-hand domain containing 1) This gene encodes an EF-hand-containing calcium binding protein. The encoded protein likely plays a role in calcium homeostasis. Mutations in this gene have been associated with susceptibility to juvenile myoclonic epilepsy and juvenile absence epilepsy. Alternatively spliced transcript variants have been described. [provided by RefSeq, Feb 2010]
EFHC1 Gene-Disease associations (from GenCC):
  • juvenile myoclonic epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0068689287).
BP6
Variant 6-52454258-G-A is Benign according to our data. Variant chr6-52454258-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 137192.
BS2
High AC in GnomAd4 at 447 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EFHC1NM_018100.4 linkc.887G>A p.Arg296His missense_variant Exon 5 of 11 ENST00000371068.11 NP_060570.2 Q5JVL4-1B2CKC5
EFHC1NM_001172420.2 linkc.830G>A p.Arg277His missense_variant Exon 6 of 12 NP_001165891.1 Q5JVL4-3B2CKC5
EFHC1NR_033327.2 linkn.2213G>A non_coding_transcript_exon_variant Exon 4 of 10

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EFHC1ENST00000371068.11 linkc.887G>A p.Arg296His missense_variant Exon 5 of 11 1 NM_018100.4 ENSP00000360107.4 Q5JVL4-1

Frequencies

GnomAD3 genomes
AF:
0.00290
AC:
441
AN:
152128
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0102
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000780
AC:
196
AN:
251418
AF XY:
0.000574
show subpopulations
Gnomad AFR exome
AF:
0.0105
Gnomad AMR exome
AF:
0.000434
Gnomad ASJ exome
AF:
0.000298
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000284
AC:
415
AN:
1461850
Hom.:
1
Cov.:
34
AF XY:
0.000223
AC XY:
162
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.00944
AC:
316
AN:
33480
American (AMR)
AF:
0.000402
AC:
18
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000306
AC:
8
AN:
26136
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39696
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000162
AC:
18
AN:
1111978
Other (OTH)
AF:
0.000778
AC:
47
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
25
50
76
101
126
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00294
AC:
447
AN:
152246
Hom.:
4
Cov.:
32
AF XY:
0.00279
AC XY:
208
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.0103
AC:
430
AN:
41546
American (AMR)
AF:
0.000654
AC:
10
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68018
Other (OTH)
AF:
0.00189
AC:
4
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
21
41
62
82
103
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000966
Hom.:
5
Bravo
AF:
0.00322
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.0120
AC:
53
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00101
AC:
123
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Juvenile myoclonic epilepsy Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Aug 19, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Absence seizure;C1850778:Myoclonic epilepsy, juvenile, susceptibility to, 1 Benign:1
Dec 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.18
T;.;.;T;T;T;T;T;T;.;T;.;.
Eigen
Benign
-0.081
Eigen_PC
Benign
-0.0042
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.93
D;D;.;D;D;D;D;D;D;D;D;.;D
MetaRNN
Benign
0.0069
T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Uncertain
2.4
.;.;.;M;.;.;.;.;.;.;.;.;.
PhyloP100
1.7
PrimateAI
Benign
0.33
T
PROVEAN
Uncertain
-3.4
.;.;.;D;.;.;.;.;.;.;.;.;D
REVEL
Benign
0.19
Sift
Benign
0.054
.;.;.;T;.;.;.;.;.;.;.;.;T
Sift4G
Benign
0.061
.;.;.;T;.;.;.;.;.;.;.;.;T
Polyphen
0.067
.;.;.;B;.;.;.;.;.;.;.;.;.
Vest4
0.28, 0.27
MVP
0.73
MPC
0.13
ClinPred
0.033
T
GERP RS
4.1
Varity_R
0.18
gMVP
0.59
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115205076; hg19: chr6-52319056; COSMIC: COSV107461977; COSMIC: COSV107461977; API